The stock of Alumis Inc (ALMS) has gone down by -10.39% for the week, with a -32.30% drop in the past month and a -51.59% drop in the past quarter. The volatility ratio for the week is 10.02%, and the volatility levels for the past 30 days are 9.85% for ALMS. The simple moving average for the past 20 days is -20.73% for ALMS’s stock, with a -54.67% simple moving average for the past 200 days.
Is It Worth Investing in Alumis Inc (NASDAQ: ALMS) Right Now?
Analysts have varying opinions on the stock, with 5 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for ALMS is 25.25M and currently, short sellers hold a 9.39% of that float. On February 27, 2025, ALMS’s average trading volume was 192.44K shares.
ALMS) stock’s latest price update
Alumis Inc (NASDAQ: ALMS) has experienced a decline in its stock price by -5.77 compared to its previous closing price of 4.85. However, the company has seen a fall of -10.39% in its stock price over the last five trading days. globenewswire.com reported 2025-02-10 that SOUTH SAN FRANCISCO, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) — Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients with immune-mediated diseases, today announced that Martin Babler, President and Chief Executive Officer of Alumis, will present at the virtual Oppenheimer 35th Annual Healthcare Life Sciences Conference on Tuesday, February 11, 2025 at 3:20 pm ET.
Analysts’ Opinion of ALMS
Many brokerage firms have already submitted their reports for ALMS stocks, with Oppenheimer repeating the rating for ALMS by listing it as a “Outperform.” The predicted price for ALMS in the upcoming period, according to Oppenheimer is $32 based on the research report published on January 30, 2025 of the current year 2025.
Robert W. Baird, on the other hand, stated in their research note that they expect to see ALMS reach a price target of $25. The rating they have provided for ALMS stocks is “Outperform” according to the report published on October 31st, 2024.
H.C. Wainwright gave a rating of “Buy” to ALMS, setting the target price at $30 in the report published on October 17th of the previous year.
ALMS Trading at -34.90% from the 50-Day Moving Average
After a stumble in the market that brought ALMS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -66.22% of loss for the given period.
Volatility was left at 9.85%, however, over the last 30 days, the volatility rate increased by 10.02%, as shares sank -30.86% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -46.24% lower at present.
During the last 5 trading sessions, ALMS fell by -10.39%, in comparison to the 20-day moving average, which settled at $5.76. In addition, Alumis Inc saw -41.86% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ALMS starting from Foresite Labs, LLC, who purchase 2,500,000 shares at the price of $16.00 back on Jul 01 ’24. After this action, Foresite Labs, LLC now owns 5,584,889 shares of Alumis Inc, valued at $40,000,000 using the latest closing price.
Foresite Capital Management V, the 10% Owner of Alumis Inc, purchase 2,500,000 shares at $16.00 during a trade that took place back on Jul 01 ’24, which means that Foresite Capital Management V, is holding 5,584,889 shares at $40,000,000 based on the most recent closing price.
Stock Fundamentals for ALMS
The total capital return value is set at -0.64.
Based on Alumis Inc (ALMS), the company’s capital structure generated 0.08 points at debt to capital in total, while cash flow to debt ratio is standing at -6.88.
Currently, EBITDA for the company is -156.89 million with net debt to EBITDA at 0.76. The liquidity ratio also appears to be rather interesting for investors as it stands at 11.26.
Conclusion
To wrap up, the performance of Alumis Inc (ALMS) has been bad in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
